Text Size
25 studies found for:    "Precocious puberty"

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
"Precocious puberty"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Treatment of Boys With Precocious Puberty
Condition: Precocious Puberty
Interventions: Drug: Spironolactone;   Drug: Testolactone;   Drug: Deslorelin
2 Unknown † Comparative Validation of the Triptorelin Test for the Diagnosis of CPP in Girls
Conditions: Central Precocious Puberty;   Sexual Precocity
Interventions: Drug: Triptorelin acetate and Gonadorelin acetate;   Drug: Gonadorelin acetate and Triptorelin acetate
3 Completed Effects of Letrozole on Precocious Puberty Due to McCune Albright Syndrome
Conditions: McCune Albright Syndrome;   Polyostotic Fibrous Dysplasia;   Precocious Puberty
Intervention: Drug: Letrozole
4 Completed Safety Extension Study Of Lupron Depot In The Treatment Of Central Precocious Puberty
Conditions: Precocious;   Leuprolide Acetate;   Luteinizing Hormone (LH);   Gonadotrophin-releasing Hormone Agonist(GnRHa);   Tanner Staging;   Depot Formulation;   Suppression of LH;   CPP;   Gonadotrophin-releasing Hormone (GnRH);   Lupron;   GnRH Analog;   Pediatrics Central Precocious Puberty
Interventions: Drug: Leuprolide acetate 11.25 mg;   Drug: Leuprolide acetate 30 mg
5 Recruiting First-Voided Urinary LH vs. GnRH-stimulation in Differentiating Slowly- From Rapidly Progressive-Precocious Puberty
Condition: Precocious Puberty, Gonadotropin-dependent
Interventions: Other: Measurement of LH in first-voided urine;   Other: collection of first-voided urine sample for LH level
6 Unknown † Analysis of Genetic and Environmental Parameters Influencing Growth Rate of Precocious Puberty Children
Condition: Central Precocious Puberty
Interventions: Drug: Triptorelin (GnRH agonists);   Drug: Leuprolide (GnRH agonists)
7 Completed
Has Results 		Efficacy and Safety Study of Pamoate of Triptorelin in Children With Precocious Puberty
Condition: Precocious Puberty
Intervention: Drug: Triptorelin pamoate 11.25mg (Decapeptyl® SR)
8 Completed Testolactone for the Treatment of Girls With LHRH Resistant Precocious Puberty
Conditions: Polyostotic Fibrous Dysplasia;   Precocious Puberty
Intervention: Drug: Testolactone
9 Active, not recruiting Effects of Triptorelin Pamoate in Children With Precocious Puberty - Follow up Study
Condition: Precocious Puberty
Intervention: Drug: Triptorelin (I.N.N.)
10 Recruiting Efficacy, Safety, and PK of Triptorelin 6-month Formulation in Patients With Central Precocious Puberty
Condition: Central Precocious Puberty
Intervention: Drug: Triptorelin 22.5 mg
11 Active, not recruiting The Clinical Trial to Evaluate the Efficacy and Safety of Luphere Depot Inj. 3.75mg(Leuprolide Acetate 3.75mg) in Patients With Precocious Puberty
Condition: Central Precocious Puberty
Intervention: Drug: Luphere depot 3.75mg(Leuprolide acetate 3.75mg)
12 Completed Purification of Testis-Stimulating Factor in Precocious Puberty
Condition: Precocious Puberty
Interventions: Drug: leuprolide;   Drug: testosterone
13 Active, not recruiting Histrelin Subcutaneous Implant in Children With Central Precocious Puberty
Condition: Central Precocious Puberty
Intervention: Drug: Histrelin Subcutaneous Implant
14 Recruiting Psychosocial Impact of Early Puberty in Girls Aged 6 to 8 Years
Condition: Early Puberty
Intervention:
15 Completed Study of Gonadotropin-Releasing Hormone Pulse Frequency in Sexual Maturation and in the Menstrual Cycle
Conditions: Hypogonadism;   Precocious Puberty
Intervention:
16 Recruiting Natural History Study of Patients With Excess Androgen
Conditions: Excess Androgen;   Congenital Adrenal Hyperplasia (CAH);   Familial Male-Limited Precocious Puberty (FMPP)
Intervention:
17 Completed
Has Results 		Study of Lupron Depot In The Treatment of Central Precocious Puberty
Condition: Puberty, Precocious
Intervention: Drug: Lupron (leuprolide acetate)
18 Recruiting The Genetic Investigation of Reproductive Disorders
Conditions: Kallmann Syndrome;   Hypogonadotropic Hypogonadism;   Hypothalamic Amenorrhea;   Polycystic Ovarian Syndrome;   Precocious Puberty
Intervention:
19 Suspended Follicle-Stimulating Hormone (FSH) and the Onset of Puberty
Conditions: Delayed Puberty;   Precocious Puberty
Interventions: Drug: Leuprolide Acetate - Early Puberty Leuprolide Visit;   Drug: Ganirelix - Early Puberty Ganirelix Visit;   Drug: Ganirelix - Delayed Puberty Ganirelix Visit;   Drug: Leuprolide Acetate- Delayed Puberty Leuprolide Visit
20 Completed
Has Results 		A Study of Leuprolide 11.25 mg and 30 mg Administered Every 3 Months to Treat Central Precocious Puberty
Condition: Puberty, Precocious
Interventions: Drug: Leuprolide acetate 11.25 mg;   Drug: Leuprolide acetate 30 mg
To Top

Previous Page Studies Shown (1-20) Next Page (21-25) Show next page of results
† Indicates status has not been verified in more than two years